CLSN Craters, BTX, CYTR, CTIC Progress Clinically, Echo Fades, DYAX Does A ... NASDAQ Pfizer Inc. ( PFE ) has prevailed in its patent dispute against generic company Actavis Inc. (previously known as Watson Laboratories Inc) related to Sirolimus, the active ingredient in RAPAMUNE, for the inhibition of organ transplant rejection. Pfizer ... |
